Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants. Methods and Findings: Women aged 15-25 years were enrolled. A 6-month persistent HPV infection (6MPI) was defined as detection of the same HPV type at two consecutive evaluations over 6 months and clearance as ≥2 typespecific HPV negative samples taken at two consecutive intervals of approximately 6 months following a positive sample. The primary endpoint was CIN grade 2 or greater (CIN2+) associated with the same HPV type as a 6MPI. Secondary endpoints were CIN1+/CIN3...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
Objective: To evaluate the outcomes of women diagnosed with high-risk HPV without cytology evidence ...
Background/objective - Having a 30-year follow-up of a cohort of women tested for HPV is a unique op...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
Background: The control arm of PATRICIA ( PApillomaTRIal against Cancer In young Adults, NCT00122681...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
BACKGROUND: The control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681...
BACKGROUND: The control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681...
The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to...
The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to...
<div><p>Background</p><p>The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults,...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
The control arm of the phase III VIVIANE (Human PapillomaVIrus: Vaccine Immunogenicity ANd Efficacy;...
Background/objective: Long-term follow-up of patients with positive tests for Human Papilloma Viruse...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
Objective: To evaluate the outcomes of women diagnosed with high-risk HPV without cytology evidence ...
Background/objective - Having a 30-year follow-up of a cohort of women tested for HPV is a unique op...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
Background: The control arm of PATRICIA ( PApillomaTRIal against Cancer In young Adults, NCT00122681...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
BACKGROUND: The control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681...
BACKGROUND: The control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681...
The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to...
The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to...
<div><p>Background</p><p>The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults,...
Background: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681)...
The control arm of the phase III VIVIANE (Human PapillomaVIrus: Vaccine Immunogenicity ANd Efficacy;...
Background/objective: Long-term follow-up of patients with positive tests for Human Papilloma Viruse...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
Objective: To evaluate the outcomes of women diagnosed with high-risk HPV without cytology evidence ...
Background/objective - Having a 30-year follow-up of a cohort of women tested for HPV is a unique op...